US approves Boehringer drug for resistant HIV

WASHINGTON (Reuters) - Boehringer Ingelheim won U.S. approval on Wednesday to sell its AIDS medicine Aptivus for treating adults with drug-resistant HIV infections in combination with Abbott Laboratories Inc.'s Norvir.

Continue to US approves Boehringer drug for resistant HIV on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz